Course Overview
Scientific advances have led to a new generation of innovative therapeutic products. These new therapeutics are called many things: cell therapies, stem cell therapies, CAR-T, gene therapies, advanced therapies, Advanced Therapeutic Medicinal Products (AMTPs). This new and exciting areas of treatments are growing year on year. But what are they? What makes them so effective? What makes them so expensive? How are they different from biopharmaceuticals and pharmaceuticals?
This training course will provide you with a comprehensive overview of how cell and gene therapies products are developed and manufactured. The course is designed for professionals who require a basic understanding of the science and technology. Once completed, you will understand what each advanced therapy is, how it is made and the challenges that must be overcome. You will also appreciate the major challenges of developing and manufacturing an ATMP including regulatory, clinical and quality issues.
Pfizer Ltd (verified owner) –
n/a
Pharmaplan (verified owner) –
n/a
Benchling (verified owner) –
It was a really good overview and now I can tailor my attention and focus on the gene and cell therapy processes that I want to dive into.
Roche Products –
n/a
Health Canada (verified owner) –
n/a
Gilead (verified owner) –
.
AmplifyBio –
n/a
Danish Medicines Agency (verified owner) –
n/a
Halmed (Hungarian Agency) (verified owner) –
Presented in a very interesting manner, all relevant details provided.
Eppendorf (verified owner) –
In my role as Regulatory Affairs Manager, I needed to gain a better understanding of the CGT field as well as challenges faced by our CGT customers to determine expectations for Quality and Regulatory requirements related to equipment. The course presented vital information and I was pleasantly surprised at the volume of information as well as the ability of the presenter to communicate complex scientific information in an understandable manner for a non-scientist.